A Form 4 filed with the SEC on August 17, 2026, discloses that Tony Tripeny, a director of Mesa Laboratories Inc /CO/, purchased 900 shares of common stock on August 13, 2026.
Key Highlights
- Reporting person: Tony Tripeny, listed as a Director of Mesa Laboratories Inc /CO/
- Transaction date: August 13, 2026
- Transaction type: Purchase (transaction code P) of 900 shares of common stock
- Purchase price: $113.69 per share
- Post-transaction ownership: 6,298 shares of common stock held directly following the transaction
- Filing signed by: John Sakys under Power of Attorney by Tony Tripeny
Mesa Laboratories Director Tony Tripeny Acquires 900 Shares at $113.69
According to the Form 4 filed with the Securities and Exchange Commission, Tony Tripeny, who is identified as a Director of Mesa Laboratories Inc /CO/ (NASDAQ:MLAB), acquired 900 shares of the company's common stock on August 13, 2026. The filing records a purchase transaction (code "P") at a price of $113.69 per share, with the shares classified as acquired (A) in the filing's Table I for non-derivative securities.
Following the reported transaction, the filing states that Tripeny beneficially owned 6,298 shares of Mesa Laboratories common stock in direct form. No derivative securities transactions were reported in Table II of the filing. The form was filed on August 17, 2026, and was signed by John Sakys under Power of Attorney by Tony Tripeny, as noted in the explanation of responses section of the document.
No amendment date is listed, indicating this is an original filing. The earliest transaction date reported is August 13, 2026, and no deemed execution date was noted for the transaction.
What Was Disclosed
The filing reports a single open-market purchase of 900 shares of Mesa Laboratories common stock by Director Tony Tripeny at $113.69 per share on August 13, 2026, bringing his directly held total to 6,298 shares.




Please wait processing your request...